SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alireza Minagar, Multiple Sclerosis: An Overview of Clinical Features, Pathophysiology, Neuroimaging, and Treatment Options, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 2014, 6, 4, 1

    CrossRef

  2. 2
    Trevor E. Davis, Katalin Kis-Toth, Attila Szanto, George C. Tsokos, Glucocorticoids Suppress T Cell Function by Up-Regulating MicroRNA-98, Arthritis & Rheumatism, 2013, 65, 7
  3. 3
    M Á Carrillo-de Sauvage, L Maatouk, I Arnoux, M Pasco, A Sanz Diez, M Delahaye, M T Herrero, T A Newman, C F Calvo, E Audinat, F Tronche, S Vyas, Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation, Cell Death and Differentiation, 2013, 20, 11, 1546

    CrossRef

  4. 4
    Ji Seon Oh, Yong-Gil Kim, Seung Geun Lee, Min Wook So, Seung Won Choi, Chang-Keun Lee, Bin Yoo, The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4+CD25+ regulatory T cells, Rheumatology International, 2013, 33, 2, 381

    CrossRef

  5. 5
    Makiko Oguma, Akira Morimoto, Akiko Takada, Yoshifumi Kashii, Tokiko Fukuda, Masato Mori, Takanori Yamagata, Hideo Sugie, Mariko Y. Momoi, Another promising treatment option for neuroblastoma-associated opsoclonus–myoclonus syndrome by oral high-dose dexamethasone pulse: Lymphocyte markers as disease activity, Brain and Development, 2012, 34, 3, 251

    CrossRef

  6. 6
    Nicole Seissler, Edgar Schmitt, Friederike Hug, Claudia Sommerer, Martin Zeier, Matthias Schaier, Andrea Steinborn, Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR+-Treg-cells in transplanted patients, Transplant Immunology, 2012, 27, 4, 157

    CrossRef

  7. 7
    H.Y. Lee, A. Dunant, P. Sekula, M. Mockenhaupt, P. Wolkenstein, L. Valeyrie-Allanore, L. Naldi, S. Halevy, J.C. Roujeau, The role of prior corticosteroid use on the clinical course of Stevens–Johnson syndrome and toxic epidermal necrolysis: a case–control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies, British Journal of Dermatology, 2012, 167, 3
  8. 8
    Adrian M. Moser, Helmut J.F. Salzer, Robert Krause, Immunoplasticity – Triggers of regulatory function, Medical Hypotheses, 2011, 77, 6, 1145

    CrossRef

  9. 9
    Tove Ragna Reksten, Karl A. Brokstad, Roland Jonsson, Johan G. Brun, Malin V. Jonsson, Implications of long-term medication of oral steroids and antimalarial drugs in primary Sjögren's syndrome, International Immunopharmacology, 2011, 11, 12, 2125

    CrossRef

  10. 10
    Farhad Jadidi-Niaragh, Abbas Mirshafiey, Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis, Immunopharmacology and Immunotoxicology, 2011, 33, 3, 545

    CrossRef

  11. 11
    Benjamin M. Greenberg, Bhupendra O. Khatri, John F. Kramer, CURRENT AND EMERGING MULTIPLE SCLEROSIS THERAPEUTICS, CONTINUUM: Lifelong Learning in Neurology, 2010, 16, 58

    CrossRef

  12. 12
    Koen Venken, Niels Hellings, Roland Liblau, Piet Stinissen, Disturbed regulatory T cell homeostasis in multiple sclerosis, Trends in Molecular Medicine, 2010, 16, 2, 58

    CrossRef

  13. You have free access to this content13
    J. M. Fletcher, S. J. Lalor, C. M. Sweeney, N. Tubridy, K. H. G. Mills, T cells in multiple sclerosis and experimental autoimmune encephalomyelitis, Clinical & Experimental Immunology, 2010, 162, 1